Digital Biomarkers Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	155 Pages	Coherent Market Insights	June, 2023	CMI18049193

Best Price Guarantee
Price	from $4,500
Length	155 Pages
Publisher	Coherent Market Insights
Published Date	June, 2023
SKU	CMI18049193

Digital Biomarkers Market, By Data Collection Tools ((Wearable Devices, Implantable Components/Sensors, Mobile/Tablet Apps, Platforms, Desktop Based Software, and Data Integration (Systems that Integrate Data)), By Application (Sleep and Movement, Cardiovascular Disease, Mood and Behavior, Pain Management, Neurodegenerative Disorders, and Respiratory Conditions), and By End User (Biopharmaceutical Companies, Providers, and Payers), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Digital biomarkers are defined as objective, quantifiable physiological & behavioral data collected and measured through digital devices such as portables, wearables, implantables, and/or digestible. The data collected by these digital devices is typically used to explain, influence, or predict health-related outcomes. Thus, the demand for digital biomarkers is increasing with a rapid pace.

Market Dynamics:

Growing prevalence of chronic diseases, rising adoption of digital healthcare solutions, increasing research and development, growing adoption of patient-centric healthcare applications, rising use of smartphones, emergence of novel wearables, and expanding therapeutic applications are major factors expected to drive growth of the global digital biomarkers market.

For instance, in February 2023, Ad Scientiam announced the launch of two ambitious programs to develop and validate digital biomarkers for self-assessment of patients suffering from generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorders (NMOSD). The programs will leverage assets, methodologies, and expertise built by Ad Scientiam over the past five years and are supported by Alexion, AstraZeneca Rare Disease.

Key features of the study:

This report provides in-depth analysis of the global digital biomarkers market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.

It profiles key players in the global digital biomarkers market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.

Key companies covered as a part of this study include AliveCor Inc., Altoida Inc., Amgen Inc., Human API, Fitbit, Inc., Biogen Inc, Bayer AG, Akili Interactive Labs, Evidation Health, Inc., GlaxoSmithKline Plc, and Eli Lilly and Company, among others.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.

The global digital biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital biomarkers market.

Detailed Segmentation:

Global Digital Biomarkers Market, By Data Collection Tools:

Wearable Devices

Implantable Components/Sensors

Mobile/Tablet Apps

Platforms

Desktop Based Software

Data Integration (Systems that Integrate Data)

Global Digital Biomarkers Market, By Application:

Sleep and Movement

Cardiovascular Disease

Mood and Behavior

Pain Management

Neurodegenerative Disorders

Respiratory Conditions

Global Digital Biomarkers Market, By End User:

Biopharmaceutical Companies

Providers

Payers

Global Digital Biomarkers Market, By Region:

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

Company Profiles:

AliveCor Inc.

Altoida Inc.

Amgen Inc.

Human API

Fitbit, Inc.

Biogen Inc.

Bayer AG

Akili Interactive Labs

Evidation Health, Inc.

GlaxoSmithKline Plc

Eli Lilly and Company

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Digital Biomarkers, By Data Collection Tools; Market Digital Biomarkers, By Application; Market Digital Biomarkers, By End User; Market Digital Biomarkers, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Increasing adoption of digital healthcare solutions; High capital investment and data security concerns; Rapid adoption of health-related mobile applications; Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. Global Digital Biomarkers Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Global Digital Biomarkers Market, By Data Collection Tools, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Wearable Devices; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Implantable Components/Sensors; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Mobile/Tablet Apps; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Platforms; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Desktop Based Software; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Data Integration (Systems that Integrate Data); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Global Digital Biomarkers Market, By Application, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Sleep and Movement; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Cardiovascular Disease; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Mood and Behavior; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Pain Management; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Neurodegenerative Disorders; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Respiratory Conditions; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
7. Global Digital Biomarkers Market, By End User, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Biopharmaceutical Companies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Providers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Payers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
8. Global Digital Biomarkers Market, By Region, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Data Collection Tools, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Data Collection Tools, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Data Collection Tools, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Data Collection Tools, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Data Collection Tools, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Data Collection Tools, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
9. Competitive Landscape: AliveCor Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Altoida Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Amgen Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Human API; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Fitbit, Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Biogen Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Bayer AG; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Akili Interactive Labs; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Evidation Health, Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; GlaxoSmithKline Plc; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Eli Lilly and Company; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Analyst Views; 10. Section; Research Methodology; About us; *Browse 24 market data tables and 28 figures on "Global Digital Biomarkers Market” - forecast to 2030